Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caterina Labanca

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Haematology|November 28, 2024
Talquetamab in Multiple Myeloma: Efficacy, Safety, and Future DirectionsCaterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology|January 7, 2025
Advances and Challenges in Quizartinib-Based FLT3 Inhibition for Acute Myeloid Leukemia: Mechanisms of Resistance and Prospective Combination TherapiesAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
Hematological Oncology|October 17, 2023
Tagraxofusp in myeloid malignanciesAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|February 5, 2025
Avatrombopag for the Treatment of Immune ThrombocytopeniaCaterina Labanca, Ernesto Vigna, Enrica Antonia Martino, et al.
Expert Opinion on Pharmacotherapy|March 19, 2024
Selinexor in multiple myelomaEnrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
European Journal of Haematology|October 13, 2024
Therapy-Related Acute Promyelocytic Leukemia: Case Series and Current InsightsAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|October 29, 2025
Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating AgentsErnesto Vigna, Antonella Bruzzese, Enrica Antonia Martino, et al.
European Journal of Haematology|March 6, 2025
Therapeutic Strategies for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal AntibodiesAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
Expert Opinion on Pharmacotherapy|April 16, 2024
Momelotinib in myelofibrosisAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
Expert Opinion on Biological Therapy|September 11, 2024
Mosunetuzumab for the treatment of follicular lymphomaCaterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Haematology|November 28, 2024
Talquetamab in Multiple Myeloma: Efficacy, Safety, and Future DirectionsCaterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
European Journal of Haematology|January 7, 2025
Advances and Challenges in Quizartinib-Based FLT3 Inhibition for Acute Myeloid Leukemia: Mechanisms of Resistance and Prospective Combination TherapiesAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
Hematological Oncology|October 17, 2023
Tagraxofusp in myeloid malignanciesAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|February 5, 2025
Avatrombopag for the Treatment of Immune ThrombocytopeniaCaterina Labanca, Ernesto Vigna, Enrica Antonia Martino, et al.
Expert Opinion on Pharmacotherapy|March 19, 2024
Selinexor in multiple myelomaEnrica Antonia Martino, Ernesto Vigna, Antonella Bruzzese, et al.
European Journal of Haematology|October 13, 2024
Therapy-Related Acute Promyelocytic Leukemia: Case Series and Current InsightsAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
European Journal of Haematology|October 29, 2025
Clinical Utility of Frailty Scoring in Elderly Acute Myeloid Leukemia Patients Treated With Venetoclax and Hypomethylating AgentsErnesto Vigna, Antonella Bruzzese, Enrica Antonia Martino, et al.
European Journal of Haematology|March 6, 2025
Therapeutic Strategies for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal AntibodiesAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
Expert Opinion on Pharmacotherapy|April 16, 2024
Momelotinib in myelofibrosisAntonella Bruzzese, Enrica Antonia Martino, Caterina Labanca, et al.
Expert Opinion on Biological Therapy|September 11, 2024
Mosunetuzumab for the treatment of follicular lymphomaCaterina Labanca, Enrica Antonia Martino, Ernesto Vigna, et al.
Pageof 6